ArticleOncotarget2016

The impact of ERBB-family germline single nucleotide polymorphisms on survival response to adjuvant trastuzumab treatment in HER2-positive breast cancer.

Sinead Toomey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.